Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Dragonfly Therapeutics
Dana-Farber Cancer Institute
Mayo Clinic
Hoffmann-La Roche
STORM Therapeutics LTD
Psyence Australia Pty Ltd
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
Pfizer
Radiopharm Theranostics, Ltd
Arvinas Inc.
Immatics US, Inc.
Tizona Therapeutics, Inc
BioInvent International AB
Essen Biotech
Essen Biotech
Genentech, Inc.
DualityBio Inc.
MacroGenics
Daiichi Sankyo
Beijing Tide Pharmaceutical Co., Ltd
National Institutes of Health Clinical Center (CC)
Second Life Therapeutics
ImmunityBio, Inc.
Innate Pharma
Novartis
OncoNano Medicine, Inc.
City of Hope Medical Center
Mayo Clinic
University of Pittsburgh
University Health Network, Toronto
GV20 Therapeutics
NeoTX Therapeutics Ltd.
Cancer Research UK
West China Hospital
HiFiBiO Therapeutics
DualityBio Inc.
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
Tempus AI